HVTN 706 - A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 3 Efficacy Study of a Heterologous Vaccine Regimen of Ad26.Mos4.HIV and Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals who Have Sex with Cis-gender Men and/or Transgender Individuals

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Healthy | HIV
  • Age: Between 18 - 59 Years
  • Gender: Male or Female

Other eligibility criteria:

We are looking for:
Cis-gender man having sex with cis-gender men and/or transgender individuals,
OR 
Transgender woman having sex with cis-gender men and/or transgender individuals,
OR 
Transgender man having sex with cis-gender men and/or transgender women (transgender man having sex exclusively with transgender men is excluded), 
OR 
Gender non-conforming individual having receptive or insertive anal and/or vaginal condomless intercourse

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

If you need assistance finding a non-cancer study or if you have any questions, please email psom-ocr@pobox.upenn.edu